Advancing Cancer Care Research in Medicare Advantage: Examining the Issues, Data, Measures, and Methods
Webinar Dates
Tuesday, August 5, 2025Thursday, August 7, 2025
Thursday, August 14, 2025
[Register Here

Purpose
Dramatic increases in Medicare Advantage (MA) enrollment over the past decade have heightened the need to examine cancer-related care quality and access within the MA program. This webinar series is designed to provide researchers with state-of-the-art information regarding:
- Available data to capture the structures of MA plans and care delivery in MA;
- Challenges and best practices to using these data; and
- Analytic approaches used to study how MA enrollment affects cancer-related care.
General Background Materials
- Webinar: Understanding Cancer Care Delivery through the Medicare Advantage Program
-
Report: MedPAC Payment Basics: Medicare Advantage Program Payment System. (PDF)
-
Agarwal et al., Comparing Medicare Advantage And Traditional Medicare: A Systematic Review
Intended Audience
This webinar series is intended for investigators who are interested in studying cancer-related care delivery in the Medicare program across the cancer-care continuum. The webinars may be particularly useful for investigators who have focused prior work on cancer-related care in Traditional (fee-for-service) Medicare (TM) AND investigators who have focused on the impact of Medicare Advantage on care for serious health conditions other than cancer.
Individuals who need reasonable accommodations to participate in this event, please contact NCIHDRP@mail.nih.gov at least five (5) business days before the event.
This webinar series will be archived on the HDRP Events webpage.
Webinar 1
Using data from the Centers for Medicare & Medicaid Services (CMS) to measure cancer-related care and outcomes in Medicare Advantage (MA)
Tuesday, August 5, 2025
1:00 pm - 3:00 pm ET
Webinar Description
Medicare claims data and related resources have been used for over 25 years to support research examining cancer-related care patterns, selected health outcomes, and the role of comorbid health conditions for beneficiaries enrolled in Traditional Medicare (TM). But little research has examined these care patterns or other outcomes for cancer survivors enrolled in MA. As a result, we have limited information regarding differences between care provided to similar patients in TM and MA, variation across MA plans, or the experience of people with cancer who change their insurance coverage between MA and TM. While some of the data resources to assess care in the MA program have been available to researchers for an extended time, MA Encounter data that parallel TM Part A and B claims are relatively recently available and have evolved in recent years and across service types in their accuracy. It is critical for researchers to understand how to best use Encounter data, including accounting for missing data and diagnosis inflation. This webinar aims to provide an overview of data resources available to study cancer-related care, to describe the challenges in measuring cancer care in MA, and to propose potential strategies for data users.
Background Materials
- Using Medicare Advantage Encounter Data in Cancer Research - NCI Webinar
- Introduction to the Use of Medicare Encounter Data for Research – ResDAC workshop and webinars
- MedPAC report: Assessing data sources for measuring health care utilization by Medicare Advantage enrollees: Encounter data and other sources. June 2024 (PDF)
- MedPAC presentations:
- Jung et al. Measuring resource use in Medicare Advantage using Encounter data
Session Chair

Amy J. Davidoff, PhD, MS
Health Economist and Program Director
Healthcare Assessment Research Branch
Healthcare Delivery Research Program
Division of Cancer Control & Population Sciences
National Cancer Institute
Moderator

Claire Ankuda, MD, MPH, MSc
Associate Professor
Geriatrics and Palliative Medicine
Icahn School of Medicine at Mount Sinai
Panelists

Helen Parsons, PhD, MPH
Professor
Division of Health Policy & Management
School of Public Health
University of Minnesota

Andy Johnson, PhD, MA
Principal Policy Analyst
Medicare Payment Advisory Commission

Caroline Carlin, PhD
Research Investigator
Department of Family Medicine and Community Health
School of Medicine
University of Minnesota
Webinar 2
Measurement and assessment of Medicare Advantage (MA) plan types, benefits, networks
Thursday, August 7, 2025
1:00 pm - 3:00 pm ET
Webinar Description
Medicare Advantage (MA) plans are quite heterogeneous, with differences across plan types (HMO, POS, PPOs and SNPs), premiums and out-of-pocket caps, benefit design for mandatory benefits, supplemental benefits, provider network designs & access, affiliations with commercial insurers or major healthcare institutions, and market environments. Understanding whether and how these plan features impact MA enrollment, plan selection, and delivery of cancer-related care requires accurate data and relevant measures. This webinar is designed to identify potential mechanisms through which plan characteristics may affect outcomes, and to describe key data sources available to describe plan characteristics, and key measures. There will be a targeted examination of provider networks, and alternative strategies and data to measure them. The panel discussion will focus on data and measurement gaps, limitations, and priorities for the future.
Background Materials
Plan type, benefits- Trends: Ryan et al. Trends in Plan Offerings, Enrollment, and Premiums in Medicare Advantage and Medigap
- MedPAC report: Provider networks and prior authorization in Medicare Advantage. June 2024 (PDF)
.
- MedPAC presentation: Provider networks and prior authorization in Medicare Advantage. November 2024 (PDF)
.
- Network data from Ideon
.
- Feyman et al. Restrictiveness of Medicare Advantage provider networks across physician specialties
.
- Raoof et al. Medicare Advantage Networks and Access to High-volume Cancer Surgery Hospitals
.
- Raoof et al. Medicare Advantage: A Disadvantage for Complex Cancer Surgery Patients
.
Session Chair

Amy J. Davidoff, PhD, MS
Health Economist and Program Director
Healthcare Assessment Research Branch
Healthcare Delivery Research Program
Division of Cancer Control & Population Sciences
National Cancer Institute
Moderator

David J. Meyers, PhD, MPH
Associate Professor
Department of Health Services, Policy & Practice
School of Public Health
Brown University
Panelists

Claire Ankuda, MD, MPH, MSc
Associate Professor
Geriatrics and Palliative Medicine
Icahn School of Medicine at Mount Sinai

Jose F. Figueroa, PhD, MPH
Associate Professor of Health Policy and Management
Harvard TH Chan School of Public Health
Harvard University

Mark Meiselbach, PhD
Assistant Professor of Health Policy and Management
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University
Webinar 3
Medicare Advantage enrollment and plan selection behaviors, and causal inference methods to address selection
Thursday, August 14, 2025
1:00 pm - 3:00 pm ET
Webinar Description
Medicare beneficiaries must actively choose to enroll in Medicare Advantage and select a plan that they expect to best meet their needs – based on benefit design, supplemental benefits, out-of-pocket costs, and provider networks. The literature provides limited information regarding the patterns of enrollment, disenrollment, and plan switching generally and among cancer survivors, and what patient sociodemographic, clinical, market, policy, and plan characteristics are associated with enrollment and plan choice. Furthermore, because enrollment and plan selection are not random, it is critical to address this when assessing causal relationships between plan characteristics and cancer-related care. This webinar is designed to address both questions – to examine current patterns of enrollment and plan switching among cancer survivors, and what we know about relevant patterns. The webinar will then examine potential study designs that support causal inference in a complex and dynamic choice environment.
Background Materials
Enrollment- Jazowsky et al. Comparing Medicare plan selection among beneficiaries with and without a history of cancer
.
- Jazowsky et al. Medicare Plan Switching Among Beneficiaries With and Without a History of Cancer
.
- Kwon et al. Medigap Protection and Plan Switching Among Medicare Advantage Enrollees With Cancer
.
- Nicholas et al. Is there an advantage? Considerations for researchers studying the effects of the type of Medicare coverage
.
Session Chair

Amy J. Davidoff, PhD, MS
Health Economist and Program Director
Healthcare Assessment Research Branch
Healthcare Delivery Research Program
Division of Cancer Control & Population Sciences
National Cancer Institute
Moderator

David J. Meyers, PhD, MPH
Associate Professor
Department of Health Services, Policy & Practice
School of Public Health
Brown University
Panelists

Jose F. Figueroa, PhD, MPH
Associate Professor of Health Policy and Management
Harvard TH Chan School of Public Health
Harvard University

Laura Hatfield, PhD
Senior Fellow
Statistics and Data Science Department
NORC at the University of Chicago

Amelia Bond, PhD, MS, MHS
Associate Professor
Division of Health Policy and Economics
Department of Population Health Sciences
Weill Cornell Medical College
Associate Director, Cornell Health Policy Center

Eric T. Roberts, PhD, MA
Associate Professor of Medicine (General Internal Medicine)
Perelman School of Medicine
Senior Fellow, Leonard Davis Institute of Health Economics
University of Pennsylvania